J. de Korne-Elenbaas

发表

Within-Host Genetic Variation in Neisseria gonorrhoeae over the Course of Infection

S. Bruisten, H. D. de Vries, J. de Korne-Elenbaas, 2022, Microbiology spectrum.

The sudden emergence of a Neisseria gonorrhoeae strain with reduced susceptibility to extended-spectrum cephalosporins, Norway

X. Didelot, D. Caugant, K. Alfsnes, 2020, bioRxiv.

The Neisseria gonorrhoeae Accessory Genome and Its Association with the Core Genome and Antimicrobial Resistance

M. Maiden, S. Bruisten, J. de Korne-Elenbaas, 2022, Microbiology spectrum.

Emergence of a cephalosporin reduced susceptible Neisseria gonorrhoeae clone between 2014-2019 in Amsterdam, the Netherlands, revealed by a genomic population analysis

S. Bruisten, H. D. de Vries, J. de Korne-Elenbaas, 2020, bioRxiv.

Simultaneous Detection of Neisseria gonorrhoeae and Fluoroquinolone Resistance Mutations to Enable Rapid Prescription of Oral Antibiotics

S. Bruisten, J. de Korne-Elenbaas, A. V. van Dam, 2020, Sexually transmitted diseases.

Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis

S. Bruisten, J. de Korne-Elenbaas, A. V. van Dam, 2021, The Journal of antimicrobial chemotherapy.

Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial.

T. Heijman, H. D. de Vries, J. de Korne-Elenbaas, 2022, The Lancet. Infectious diseases.

Increased clonality among Neisseria gonorrhoeae isolates during the COVID-19 pandemic in Amsterdam, the Netherlands

H. D. de Vries, J. de Korne-Elenbaas, A. V. van Dam, 2023, Microbial genomics.

Software testing in microbial bioinformatics: a call to action

Luis Pedro Coelho, L. Katz, J. de Korne-Elenbaas, 2022, Microbial genomics.

The inter-continental population dynamics of Neisseria gonorrhoeae

F. Balloux, Y. Grad, X. Didelot, 2023, bioRxiv.